[144] HORACE MANN EDUCATORS CORP /DE/ SEC Filing

Rhea-AI Filing Summary

Filing overview: This Form 144 reports proposed and recent sales of Horace Mann Educators Corp (HMN) common stock by an insider, identifying planned sale of 5,000 shares with an aggregate market value of $224,050 to occur on 10/01/2025 on the NYSE. The shares were acquired by restricted stock vesting on 01/01/2023 and were paid as compensation. The filer also disclosed three sales in the past three months totaling 15,000 shares for gross proceeds of $654,550 (July, August, September 2025). The total outstanding common shares shown is 40,695,729, making the proposed 5,000-share sale a very small fraction of outstanding stock.

Positive

• Filer disclosed proposed sale and recent sales, demonstrating compliance with Rule 144 notice requirements.
• The securities were acquired via restricted stock vesting, indicating sales are from compensation rather than open-market purchases.

Negative

• Insider sold 15,000 shares in the past three months for gross proceeds of $654,550, which some investors may interpret as insider selling pressure.
• The filing does not state a 10b5-1 trading plan adoption date, so the timing could be perceived as discretionary rather than pre-planned.

Insights

Securities Analyst

TL;DR: Routine insider sales disclosed; volumes are immaterial relative to shares outstanding and appear driven by vested compensation.

The filer reports a planned sale of 5,000 shares valued at $224,050 and prior sales of 15,000 shares netting $654,550 over three months. The shares were acquired via restricted stock vesting and paid as compensation, which suggests these are tax/liquidity-driven dispositions rather than a change in control or a financing event. Given the issuer's reported outstanding share count of 40,695,729, the single proposed sale represents roughly 0.012% of outstanding shares, indicating limited market impact. Disclosure appears to meet Rule 144 notice requirements.

Corporate Governance Expert

TL;DR: Filing documents compliance with Rule 144 and indicates insider is monetizing vested equity; no governance red flags shown.

The Form 144 identifies the nature of acquisition as restricted stock vesting and lists broker details for the proposed transaction, which supports procedural compliance. Repeated monthly sales in July–September followed by another planned sale could reflect a systematic liquidation plan, but no explicit 10b5-1 plan date or other instructions are provided in the filing remarks. Absent additional context, the disclosure does not demonstrate material adverse governance or regulatory concerns.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	5000	224050.00	40695729	10/01/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	01/01/2023	Restricted Stock Vesting	Issuer			5000	01/01/2023	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Marita Zuraitis 1 Horace Mann Plaza Springfield IL 62715-00	Common	07/01/2025	5000	214350.00
Marita Zuraitis 1 Horace Mann Plaza Springfield IL 62715-00	Common	08/01/2025	5000	211400.00
Marita Zuraitis 1 Horace Mann Plaza Springfield IL 62715-00	Common	09/02/2025	5000	228800.00

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What insider sales does the HMN Form 144 disclose?

The filing discloses a proposed sale of 5,000 common shares (market value $224,050) and three prior sales of 5,000 shares each on 07/01/2025, 08/01/2025, and 09/02/2025.

How much did the insider receive from recent HMN stock sales?

Gross proceeds from the three prior sales total $654,550 (214,350; 211,400; 228,800).

How were the shares acquired that are being sold under HMN Form 144?

The shares were acquired on 01/01/2023 through restricted stock vesting and payment is listed as compensation.

Where will the proposed HMN sale be executed and when?

The proposed sale of 5,000 shares is to be executed via Fidelity Brokerage Services LLC on the NYSE with an approximate date of 10/01/2025.

What proportion of HMN outstanding shares does the proposed sale represent?

The filing shows 40,695,729 shares outstanding; the 5,000-share proposed sale is approximately 0.012% of outstanding shares.